Literature DB >> 2711310

Malignant transformation of recurrent meningioma with pulmonary metastases.

D R LeMay1, M N Bucci, S M Farhat.   

Abstract

A patient presented with a histologically benign intracranial meningioma which, after multiple recurrences, underwent malignant transformation. The patient survived 18 years following initial presentation. Pulmonary metastases were present over the final 8 years. Eleven subtotal resections of the meningioma were performed, including exenteration of the right eye and a thoracotomy. Radiation therapy and chemotherapy were relatively ineffective. The problem and treatment of recurrent meningiomas is briefly reviewed.

Entities:  

Mesh:

Year:  1989        PMID: 2711310     DOI: 10.1016/0090-3019(89)90068-2

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  14 in total

1.  Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma.

Authors:  S Ozaki; T Nishizaki; H Ito; K Sasaki
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Surgical resection of pulmonary metastases from meningioma: report of a case.

Authors:  Ryu Kanzaki; Masahiko Higashiyama; Ayako Fujiwara; Toshiteru Tokunaga; Jun Maeda; Jiro Okami; Yasuhiko Tomita; Ken Kodama
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

3.  Recurrent meningioma with malignant transformation: a case report and literature review.

Authors:  Junwen Wang; Lei Wang; Bo Luo; Zhi Chen; Zuojun Xiong; Mingbo Fang; Jun Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Tissue-specific transplantation antigen P35B (TSTA3) immune response-mediated metabolism coupling cell cycle to postreplication repair network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by biocomputation.

Authors:  Lin Wang; Juxiang Huang; Minghu Jiang; Hong Lin
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

5.  Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.

Authors:  T Yazaki; Y Takamiya; P C Costello; T Mineta; A G Menon; S D Rabkin; R L Martuza
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 6.  Chemotherapy for meningiomas.

Authors:  A P Kyritsis
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

Review 7.  Treatment of meningioma: an update.

Authors:  Anthony L D'Ambrosio; Jeffrey N Bruce
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

Review 8.  Distant metastases in meningioma: an underestimated problem.

Authors:  Alexey Surov; Sebastian Gottschling; Julia Bolz; Malte Kornhuber; Alex Alfieri; Hans-Jürgen Holzhausen; Jasmin Abbas; Sabrina Kösling
Journal:  J Neurooncol       Date:  2013-02-13       Impact factor: 4.130

9.  Abundant immunohistochemical expression of dopamine D2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence.

Authors:  G Trott; J F S Pereira-Lima; C G S Leães; N P Ferreira; L M Barbosa-Coutinho; M C Oliveira
Journal:  Braz J Med Biol Res       Date:  2015-03-03       Impact factor: 2.590

10.  Transformation of a meningioma with atypical imaging.

Authors:  Ashish Kumar; Chandrashekhar Deopujari; Vikram Karmarkar
Journal:  Asian J Neurosurg       Date:  2016 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.